SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MedImmune -- Ignore unavailable to you. Want to Upgrade?

To: Aggie who wrote (200)2/29/2000 12:37:00 PM
From: Sandman  Respond to of 416
 
Short term we could go back and test 175 area but I think we are going to break through 200 and run to 225. Long term this stock will do great. Try to buy it on a bad biotech day. Good luck. JB



To: Aggie who wrote (200)2/29/2000 12:38:00 PM
From: Bosco  Read Replies (2) | Respond to of 416
 
Hi Aggie - there is no guarantee, but I bot at 180 when S&P upgraded her to a 5 stars. The rationale is her pipeline and that she is trading 1/2 of her peer. This is a rare biotech with a trailing p/e! A 3-for-1 doesn't hurt. I would like to think she is still in the 5rd inning!

best, Bosco


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News